Literature DB >> 11096745

Mood Disorders in Neurologic Illness.

.   

Abstract

Patients with neurologic illness frequently develop secondary mood disorders that are broadly categorized as unipolar or bipolar. Accurate diagnosis is essential because the treatment of unipolar disorders is markedly different from that of bipolar disorders. Aggressive treatment of mood disorders improves quality of life, reduces morbidity and mortality, and may prevent worsening of both psychiatric and neurologic disease. Antidepressants and psychotherapy are both effective for patients suffering from depressive disorders. Choice of antidepressant depends on the patient's particular symptom complex; medication side effects, which may exacerbate the underlying neurologic condition; potential interactions with other drugs; and costs. Bipolar disorder associated with neurologic illness typically requires treatment with mood stabilizers such as lithium, divalproex sodium, carbamazepine, or verapamil. Although psychotherapy in combination with pharmacologic therapy improves the outcome in bipolar illness, psychotherapy alone is not effective for this condition. Electroconvulsive therapy is an effective treatment for both depression and mania. It may have particular usefulness in Parkinson's disease, for which it has been shown to improve the movement disorder itself. Treatment of bipolar disorder, psychotic depression, or refractory depression is complicated and should be referred to a psychiatrist.

Entities:  

Year:  2000        PMID: 11096745     DOI: 10.1007/s11940-000-0016-z

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  83 in total

1.  A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

Authors:  G Petracca; A Tesón; E Chemerinski; R Leiguarda; S E Starkstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

Review 2.  Psychosocial interventions as an adjunct to pharmacotherapy in bipolar disorder.

Authors:  S V Parikh; V Kusumakar; D R Haslam; R Matte; V Sharma; L N Yatham
Journal:  Can J Psychiatry       Date:  1997-08       Impact factor: 4.356

3.  Suicidal plans following spinal cord injury: a six month study.

Authors:  Y Kishi; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

4.  The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.

Authors:  W J Burke; V Dewan; S P Wengel; W H Roccaforte; G C Nadolny; D G Folks
Journal:  Int J Geriatr Psychiatry       Date:  1997-05       Impact factor: 3.485

5.  Depression and schizophrenia in epilepsy: social and biological risk factors.

Authors:  E B Schmitz; M M Robertson; M R Trimble
Journal:  Epilepsy Res       Date:  1999-05       Impact factor: 3.045

6.  Nortriptyline treatment of post-stroke depression: a double-blind study.

Authors:  J R Lipsey; R G Robinson; G D Pearlson; K Rao; T R Price
Journal:  Lancet       Date:  1984-02-11       Impact factor: 79.321

7.  Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations.

Authors:  M E Thase; J B Greenhouse; E Frank; C F Reynolds; P A Pilkonis; K Hurley; V Grochocinski; D J Kupfer
Journal:  Arch Gen Psychiatry       Date:  1997-11

8.  The effect of alcohol and substance abuse on the course of bipolar affective disorder.

Authors:  J A Feinman; D L Dunner
Journal:  J Affect Disord       Date:  1996-02-12       Impact factor: 4.839

9.  Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life.

Authors:  R A Sweet; B H Mulsant; B Gupta; A H Rifai; R E Pasternak; A McEachran; G S Zubenko
Journal:  Arch Gen Psychiatry       Date:  1995-06

10.  Manic-depressive and pure manic states after brain lesions.

Authors:  S E Starkstein; P Fedoroff; M L Berthier; R G Robinson
Journal:  Biol Psychiatry       Date:  1991-01-15       Impact factor: 13.382

View more
  3 in total

Review 1.  Review on clinical update of essential tremor.

Authors:  Wei Chunling; Xiao Zheng
Journal:  Neurol Sci       Date:  2016-01-09       Impact factor: 3.307

2.  Substance Use Disorders and Neurologic Illness.

Authors:  Robert D. Davies; Christian Thurstone; Kelly Woyewodzic
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

3.  Bipolar Disorder in Neurologic Illness.

Authors:  Christopher D. Schneck
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.